1. Home
  2. AIFU vs TXMD Comparison

AIFU vs TXMD Comparison

Compare AIFU & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFU
  • TXMD
  • Stock Information
  • Founded
  • AIFU 1998
  • TXMD 2008
  • Country
  • AIFU China
  • TXMD United States
  • Employees
  • AIFU N/A
  • TXMD N/A
  • Industry
  • AIFU
  • TXMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIFU
  • TXMD Health Care
  • Exchange
  • AIFU NYSE
  • TXMD Nasdaq
  • Market Cap
  • AIFU 12.2M
  • TXMD 12.8M
  • IPO Year
  • AIFU 2007
  • TXMD N/A
  • Fundamental
  • Price
  • AIFU $6.47
  • TXMD $1.14
  • Analyst Decision
  • AIFU
  • TXMD
  • Analyst Count
  • AIFU 0
  • TXMD 0
  • Target Price
  • AIFU N/A
  • TXMD N/A
  • AVG Volume (30 Days)
  • AIFU 193.4K
  • TXMD 60.7K
  • Earning Date
  • AIFU 07-11-2025
  • TXMD 08-11-2025
  • Dividend Yield
  • AIFU N/A
  • TXMD N/A
  • EPS Growth
  • AIFU 61.54
  • TXMD N/A
  • EPS
  • AIFU 23.02
  • TXMD N/A
  • Revenue
  • AIFU $247,815,758.00
  • TXMD $1,841,000.00
  • Revenue This Year
  • AIFU N/A
  • TXMD $427.09
  • Revenue Next Year
  • AIFU N/A
  • TXMD N/A
  • P/E Ratio
  • AIFU $0.27
  • TXMD N/A
  • Revenue Growth
  • AIFU N/A
  • TXMD 53.55
  • 52 Week Low
  • AIFU $1.50
  • TXMD $0.70
  • 52 Week High
  • AIFU $7.59
  • TXMD $2.44
  • Technical
  • Relative Strength Index (RSI)
  • AIFU N/A
  • TXMD 44.80
  • Support Level
  • AIFU N/A
  • TXMD $0.98
  • Resistance Level
  • AIFU N/A
  • TXMD $1.21
  • Average True Range (ATR)
  • AIFU 0.00
  • TXMD 0.09
  • MACD
  • AIFU 0.00
  • TXMD 0.00
  • Stochastic Oscillator
  • AIFU 0.00
  • TXMD 64.00

About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS

AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, capital flow and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services. The company operated in two segments: the insurance agency segment, which derives maximum revenue, consists of providing agency services for distributing life insurance products and non-life insurance products on behalf of insurance companies, and the claims adjusting segment consisting of providing pre-underwriting survey services, claims adjusting services, disposal of residual value services, loading/unloading supervision services and consulting services.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: